Recommendation for supportive care in patients receiving concurrent chemotherapy and radiotherapy for lung cancer
Concurrent chemotherapy and radiotherapy (CCRT) followed by durvalumab immune therapy in appropriate patients is considered to be the standard of care…
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
6 January 2020
|
| In: |
Annals of oncology
Year: 2020, Jahrgang: 31, Heft: 1, Pages: 41-49 |
| ISSN: | 1569-8041 |
| DOI: | 10.1016/j.annonc.2019.10.003 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.annonc.2019.10.003 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0923753419354092 
|
| Verfasserangaben: | D. De Ruysscher, C. Faivre-Finn, K. Nackaerts, K. Jordan, J. Arends, J.Y. Douillard, U. Ricardi & S. Peters |
| Zusammenfassung: | Concurrent chemotherapy and radiotherapy (CCRT) followed by durvalumab immune therapy in appropriate patients is considered to be the standard of care… |
|---|---|
| Beschreibung: | Gesehen am 02.04.2020 |
| Beschreibung: | Online Resource |
| ISSN: | 1569-8041 |
| DOI: | 10.1016/j.annonc.2019.10.003 |